LexDanaLexDanabeta
Inventor

Abdelmalik Slassi

Inventor
Mississauga, CA

Overview

50→
Patents
1997–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 50 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds43%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
A61KPreparations for medical, dental or toiletry purposes13%
C07CAcyclic or carbocyclic compounds5%
C07BGeneral methods of organic chemistry2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C07HSugars1%
C07KPeptides1%
PatentTitleYear
10,696,670Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins202010,604,476Fluorinated amide derivatives and their uses as therapeutic agents202010,428,030Heterocycle derivatives and their use for the treatment of CNS disorders201910,259,809Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins20199,441,012'Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitors'20168,450,336'Use of D-serine derivatives for the treatment of anxiety disorders'20138,377,940'Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842'20138,377,939'Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842'20138,153,638'Metabotropic glutamate-receptor-potentiating isoindolones'20128,148,394'Azaindoles having serotonin receptor affinity'20127,968,570'Isoindolone compounds and their use as metabotropic glutamate receptor potentiators'20117,960,422'Pharmaceutically active compounds containing tetrazolyl and triazolyl rings'20117,935,703'Piperazines and piperidines as Mglur5 potentiators'20117,902,401'Fluorinated compounds'20117,868,008'Substituted isoindolones and their use as metabotropic glutamate receptor potentiators'20117,816,354'Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators'20107,807,706'Metabotropic glutamate-receptor-potentiating isoindolones'20107,799,792'Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841'20107,790,717'Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators'20107,772,235'mGluR5 modulators'20107,691,892'Tetrazole compounds and their use as metabotropic glutamate receptor antagonists'20107,678,796'MGluR5 modulators I'20107,585,881'Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists'20097,576,077'Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists'20097,485,722'Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators'20097,476,684'Compounds for the treatment of neurological, psychiatric or pain disorders'20097,456,200'Compounds'20087,268,127'Azaindoles having serotonin receptor affinity'20077,112,595'Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists'20067,074,809'Compounds'20066,916,818'Azaindoles having serotonin receptor affinity'20056,897,215'Compounds having 5-HT6 receptor antagonist activity'20056,716,837'Heterocyclic compounds for the treatment of migraine'20046,686,374'Azaindoles having serotonin receptor affinity'20046,660,753'Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists'20036,635,639'Use of N-alkylamino-heterocylic compounds for the treatment of migraine'20036,562,809'3-bicycloindole compounds'20036,380,242'N-alkylamino-indoles for the treatment of migraine'20026,329,390'5-Bicycloindole compounds'20016,251,893'Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity'20016,191,141'Azaindoles having serotonin receptor affinity'20016,133,287'Piperidine-indole compounds having 5-HT.sub.6 affinity'20006,103,743'Unsaturated amino acid derivatives'20006,100,291'Pyrrolidine-indole compounds having 5-HT.sub.6 affinity'20005,998,438'5-cyclo indole compounds'19995,998,462'5-alkyl indole compounds'19995,856,510'5-alkenyl and 5-alkynyl indole compounds'19995,770,742'Thiophene-tryptamine derivatives'19985,654,431'5-alkoxy tryptamine derivatives'19975,627,194'Anti-viral guanidino-substituted compounds'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2000Patents assigned to ALLELIX BIOPHARMA (7)· patent assignee history
1997–2020Based in Mississauga, CA· patent location history
1997–1998Based in Brampton, CA· patent location history
2000–2013Based in Ontario, CA· patent location history
2001–2007Patents assigned to NPS ALLELIX CORP (10)· patent assignee history
2003–2013Patents assigned to NPS PHARMA INC (5)· patent assignee history
2006–2013Patents assigned to ASTRAZENECA AB (21)· patent assignee history
2006–2011Based in Toronto, CA· patent location history
2012–2013Patents assigned to SLASSI ABDELMALIK (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ASTRAZENECA AB212006–2013
NPS ALLELIX CORP102001–2007
ALLELIX BIOPHARMA71997–2000
NPS PHARMA INC52003–2013
SLASSI ABDELMALIKself52012–2013
Locations
LocationPatentsSpan
Mississauga, CA381997–2020
Ontario, CA52000–2013
Toronto, CA52006–2011
Brampton, CA21997–1998